Post-translational modification of CaaX motifs provides a means to regulate cell signaling proteins, including Ras. The processing of CaaX motifs involves three sequentially acting enzymes: protein prenyltransferases, prenyI-CaaX proteases, and isoprenylcysteine carboxyl methyltransferase (ICMT). Pharmacologic inhibition of prenyltransferase has shown utility as an anti-cancer therapy. Biochemical inhibition of ICMT confers resistance to Ras dependent oncogenic transformation. Pharmacologic inhibitors of ICMT are lacking but would provide an avenue for therapeutic development. This study proposes to study the structure and function of ICMT to better understand its enzymatic mechanism, structure, and to develop inhibition strategies. This process will include purification and solublization of ICMT, accompanied by enzymatic analysis to insure activity and determine the mechanism of action for ICMT. Additionally the structure of human ICMT will be determined for use in aiding enzyme inhibitor design and further understanding of the molecular mechanism of ICMT methylation of proteins. This data will provide a detailed description of the biochemical and structural properties of ICMT, with a focus on inhibition.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM073420-02
Application #
7017737
Study Section
Special Emphasis Panel (ZRG1-F04A (20))
Program Officer
Fabian, Miles
Project Start
2005-02-01
Project End
2007-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
2
Fiscal Year
2006
Total Cost
$48,796
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705